Update and validation of the lifetime cardiovascular risk in Spain: IBERLIFERISK2.

[1]  Danielle M. Enserro,et al.  Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study , 2022, Circulation.

[2]  I. V. Van Gelder,et al.  2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.

[3]  D. Fernández,et al.  Effectiveness of an Intervention Aimed at Improving Information for Patients with High Cardiovascular Risk: INFORISK Clinical Trial , 2021, International journal of environmental research and public health.

[4]  J. Boer,et al.  Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people. , 2020, European heart journal.

[5]  C. Brotons,et al.  Estimación del riesgo cardiovascular de por vida (IBERLIFERISK): una herramienta nueva en prevención primaria de las enfermedades cardiovasculares , 2019, Revista Española de Cardiología.

[6]  L. Ruilope,et al.  Comparison of application of different methods to estimate lifetime cardiovascular risk , 2016, European journal of preventive cardiology.

[7]  A. Zanchetti,et al.  Estimating the glomerular filtration rate in the Spanish working population: chronic kidney disease prevalence and its association with risk factors , 2014, Journal of hypertension.

[8]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[9]  Heart Protection Study Collaborative Group Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial , 2011, Lancet.

[10]  Carol Coupland,et al.  Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database , 2010, BMJ : British Medical Journal.

[11]  Ralph B D'Agostino,et al.  Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age , 2006, Circulation.

[12]  O. Aalen Nonparametric Inference for a Family of Counting Processes , 1978 .